June 8, 2022
Mineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing…
Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company committed to developing a best-in-class, novel therapy for the treatment of hypertension,…